Clinical Trial Update: Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

An early-phase study evaluating sotatercept (ACE-011) in combination with lenalidomide or pomalidomide and dexamethasone for relapsed/refractory multiple myelom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Pomalidomide (Pomalidomide)
• Sotatercept (sotatercept)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Multiple Myeloma | Phase 1 | Status: ACTIVE_NOT_RECRUITING